Infrastructure

At Kilitch Drugs, we are committed to maintaining state-of-the-art manufacturing facilities that adhere to the highest standards of quality and regulatory compliance. Our plants are strategically located across India and Africa, ensuring we meet the growing demand for high-quality pharmaceutical products on a global scale.

Unit 1:

Mumbai Plant

Our Mumbai Unit is equipped with advanced facilities designed for the production of high‑precision pharmaceutical products including Sterile preparations - Dry Powders for injection (DPI), Small Volume Parenterals (SVP) in ampoules and vials, as well as ophthalmic and nasal solutions to ensure compliance with global GMP standards.

Unit 2:

Ethiopia Plant

Located in Ethiopia, this is the largest Cephalosporin manufacturing plant in East Africa, designed to produce a wide range of Cephalosporin products, including tablets, capsules, injectables, dry powders for suspension, and syrups. This facility aims to lead in the African markets, fulfilling local demand for high-quality generics previously imported from other countries.

Unit 3:

Pen, Maharashtra Plant

Our Pen Unit, currently under construction in Maharashtra, India, is set to be a Green Field project designed to meet international regulatory standards such as WHO, EU, and USFDA GMP. This plant will focus on manufacturing nutraceuticals, injectables, ophthalmic products, and oral solid dosage (OSD) forms. With enhanced capacity, it aims to meet the growing demand across the global markets. The commercial production is expected to be fully operational by the end of FY 2025-2026.